Mohammed Milhem
University of Iowa(US)University of Iowa Holden Comprehensive Cancer Center
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Immunotherapy and Immune Responses, Cutaneous Melanoma Detection and Management, Sarcoma Diagnosis and Treatment
Most-Cited Works
- → Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma(2015)2,539 cited
- → Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma(2012)2,130 cited
- → Improved survival with MEK Inhibition in BRAF-mutated melanoma for the METRIC Study Group(2012)1,342 cited
- → Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma(2021)828 cited
- → Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial(2015)817 cited
- → Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials(2018)726 cited